A protocol for genetic evaluation of patients with multiple colorectal adenomas and without evidence of APC gene mutation

Israel Medical Association Journal

Volumn 12, Issue 9, 2010, Pages 549-553

  Rosner, Guy ^a   Rozen, Paul ^a   Bercovich, Dani ^b,c   Shochat, Chen ^b   Solar, Irit ^a   Strul, Hana ^a   Kariv, Revital ^a   Halpern, Zamir ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL HAI COLLEGE   (Israel)

^c UNIVERSITY OF HAIFA   (Israel)

Author keywords

Adenomas; APC negative polyposis; Colorectal cancer; MUTYH

Indexed keywords

APC PROTEIN; DNA GLYCOSYLASE MUTY; PROTEIN MLH1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; COLORECTAL ADENOMA; COPY NUMBER VARIATION; DIFFERENTIAL DIAGNOSIS; DOMINANT INHERITANCE; EXON; FEMALE; GENE DELETION; GENE DUPLICATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; JEW; MALE; MICROSATELLITE INSTABILITY; MLH1 GENE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MUTYH GENE; NEGRO; RECESSIVE INHERITANCE; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE;

ADENOMATOUS POLYPOSIS COLI; ADULT; AGED; COHORT STUDIES; COLORECTAL NEOPLASMS; DNA GLYCOSYLASES; FEMALE; GENES, APC; GENETIC TESTING; HUMANS; ISRAEL; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; YOUNG ADULT;

EID: 78049280314     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Rozen P, Levin B, Young GP. Who are at risk for familial colorectal cancer and how can they be managed? In: Rozen P, Young GP, Levin B, Spann SJ, eds. Colorectal Cancer in Clinical Practice: Prevention, Early Detection and Management. 2nd edn. London: Taylor and Francis, 2002: 55-66.
2. Grady WM. Genetic testing for high-risk colon cancer patients. Gastroenterology 2003; 124: 1574-94.
3. Nishisho I, Nakamura Y, Miyoshi Y, et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991; 253: 665-9.
4. Half E, Bercovich D, Rozen P. Review: familial adenomatous polyposis. Orphanet J Rare Dis 2009; 4: 22. http://www.ojrd.com/content/4/1/22 (accessed August 2010)
5. Lamlum H, Al Tassan N, Jaeger E, et al. Germline APC variants in patients with multiple colorectal adenomas, with evidence for the particular importance of E1317Q. Hum Mol Genet 2000; 9: 2215-21.
6. Al-Tassan N, Chmiel NH, Maynard J, et al. Inherited variants of MYH associated with somatic G:CaT:A mutations in colorectal tumors. Nat Genet 2002; 30: 227-32.
7. Sampson JR, Dolwani S, Jones S, et al. Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet 2003; 362: 39-41.
8. Sieber OM, Lipton L, Crabtree M, et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 2003; 348: 791-9.
9. Jones N, Vogt S, Nielsen M, et al. Increased colorectal cancer incidence in obligate carriers of heterozygous mutations in MUTYH. Gastroenterology 2009; 137: 489-94.
10. Farrington SM, Tenesa A, Barnetson R, et al. Germline susceptibility to colorectal cancer due to base-excision repair gene defects. Am J Hum Genet 2005; 77: 112-19.
11. Enholm S, Hienonen T, Suomalainen A, et al. Proportion and phenotype of MYH-associated colorectal neoplasia in a population-based series of Finnish colorectal cancer patients. Am J Pathol 2003; 163: 827-32.
12. Boparai KS, Dekker E, Van Eeden S, et al. Hyperplastic polyps and sessile serrated adenomas as a phenotypic expression of MYH-associated polyposis. Gastroenterology 2008; 135: 2014-18.
13. Vogt S, Jones N, Christian D, et al. Expanded extracolonic tumor spectrum in MUTYH-associated polyposis. Gastroenterology 2009; 137: 1976-85.
14. Croitoru ME, Cleary SP, Di Nicola N, et al. Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. J Natl Cancer Inst 2004; 96: 1631-4.
15. Cleary SP, Cotterchio M, Jenkins MA, et al. Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study. Gastroenterology 2009; 136: 1251-60.
16. de Jong AE, Morreau H, van Puijenbroek M, et al. The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC. Gastroenterology 2004; 126: 42-8.
17. Vasen HFA, Watson P, Mecklin J-P, Lynch HT, and the ICG-HNPCC. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 1999; 116: 1453-6.
18. Jasperson KW, Blazer KR, Lowstuter K, Weitzel JN. Working through a diagnostic challenge: colonic polyposis, Amsterdam criteria, and a mismatch repair mutation. Fam Cancer 2008; 7: 281-5.
19. Umar A, Boland CR, Terdiman JP, et al, Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatillite instability. J Natl Cancer Inst 2004; 96: 261-8.
20. Hall MJ, Liberman E, Dulkart O, et al. Risk of colorectal neoplasia associated with the adenomatous polyposis coli E1317Q variant. Ann Oncol 2009; 20: 1517-21.
21. Renkonen ET, Nieminen P, Abdel-Rahman WM, et al. Adenomatous polyposis families that screen APC mutation-negative by conventional methods are genetically heterogeneous. J Clin Oncol 2005; 23: 5651-9.
22. Gatalica Z, Torlakovic E. Pathology of the hereditary colorectal carcinoma. Fam Cancer 2008; 7: 15-26.